NCC-MRT1-C1

$600$1,500

SKU: N/A Category:

Description

Cell line name NCC-MRT1-C1
Accession CVCL_C4MW
Resource Identification Initiative To cite this cell line use: NCC-MRT1-C1 (RRID:CVCL_C4MW)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Doubling time: 30 hours (PubMed=35927606).
Omics: SNP array analysis.
Derived from site: In situ; Left thigh, hypodermis;      UBERON=UBERON_0000376+UBERON_0002072.
Sequence variations
Gene deletion; HGNC; 11103; SMARCB1; Zygosity=Homozygous (PubMed=35927606).
Disease Extrarenal rhabdoid tumor (NCIt: C6586)
Rhabdoid tumor (ORDO: Orphanet_69077)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 18Y
Category Cancer cell line
STR profile

    Source(s): PubMed=35927606

    Markers:

Amelogenin X
CSF1PO 11,12
D5S818 10,11
D7S820 11
D13S317 9,12
D16S539 10,11
D21S11 31.2,33.2
TH01 9
TPOX 8,11
vWA 14,19

Publications
PubMed=35927606; DOI=10.1007/s13577-022-00751-z
Akiyama T., Yoshimatsu Y., Noguchi R., Sin Y., Tsuchiya R., Ono T., Sato C., Kojima N., Yoshida A., Kawai A., Ohtori S., Kondo T.
Establishment and characterization of NCC-MRT1-C1: a novel cell line of malignant rhabdoid tumor.
Hum. Cell 35:2002-2010(2022)

Cross-references
Encyclopedic resources Wikidata; Q116049880

Additional information

ユーザー種別

Academia/non-profit organization, For-profit organization

Reviews

There are no reviews yet.

Be the first to review “NCC-MRT1-C1”

Your email address will not be published. Required fields are marked *

CAPTCHA